US 12,034,739

Application 17/580,721 · Granted Jul 9, 2024

Verification platform

Estimated expiration

January 15, 2043

16y 59d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Jan 21, 2022
+ 20 years
Jan 21, 2042
PTA +359d
Jan 15, 2043
No TD
—
Final
Jan 15, 2043

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
January 21, 2022
Earliest effective filing
January 21, 2022
Issue date
July 9, 2024
PTA
+359 days
Base expiry (before PTA)
January 21, 2042

January 21, 2022 + 20 years = January 21, 2042 + 359 PTA days = January 15, 2043

  • PRO63/139,839 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/580,721 · US 12,034,739

PatentReply compiles the prosecution history behind US 12,034,739: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12034739

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.